Randomized-controlled Trial of Preoperative Inspiratory Muscle Training on Postoperative Complications (INSPIRA)

January 4, 2026 updated by: University of Zurich

Randomized-controlled Trial of Spirometry-Assisted Preoperative INSPIRAtory Muscle Training on Postoperative Complications in Abdominal Surgery in a Single Tertiary Referral Centre

Rehabilitation strategies after abdominal surgery enhance recovery and improve outcome. A cornerstone of rehabilitation is respiratory physiotherapy with inspiratory muscle training to enhance pulmonary function. Prehabilitation is the process of enhancing functional capacity before surgery in order to compensate for the stress of surgery and postoperative recovery. There is growing interest in deploying pre-habilitation interventions prior to surgery.

The aim of this study is to assess the impact of preoperative inspiratory muscle training on postoperative overall morbidity. The question is, whether inspiratory muscle training prior to elective abdominal surgery reduces the number of postoperative complications and their severity grade.

Study Overview

Detailed Description

INSPIRA is a prospective randomized-controlled single-center trial, non-blinded The aim of this study is to assess the impact of preoperative inspiratory muscle training on postoperative overall morbidity. The question is, whether inspiratory muscle training prior to elective abdominal surgery reduces the number of post-operative complications and their severity grade.

Furthermore, the impact of preoperative inspiratory muscle training on postoperative physiotherapeutic performance as surrogate of convalescence is assessed, too.

Patients will be instructed by physiotherapists to perform inspiratory muscle training containing of 30 breaths twice a day for 14-18 days before surgery using Power®Breathe KHP2.

Primary outcome is Comprehensive Complication Index (CCI) at 90 days after surgery. The CCI expresses morbidity on a con-tinuous numeric scale from 0 (no complication) to 100 (death) by weighing all postoperative complications according to the Clavien-Dindo classification for their respective severity.

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Informed Consent as documented by signature (Appendix Patient Informed Consent Form)
  • Planned abdominal surgery with planned duration >2hours (disease localization: upper vs. lower gastro intestinal, HPB, hernia, others)
  • Planned surgery at least two weeks after inclusion at outpatient clinic
  • Male and female patient over 18 years

Exclusion Criteria:

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, of the participant
  • Known or suspected non-compliance, drug or alcohol abuse,
  • Previous enrolment into the current study
  • Participation in another study with inspiratory muscle training within 30 days preceding or during this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training arm
Patients perform inspiratory muscle training containing of 30 breaths twice a day for 14-18 days before surgery.
Physiotherapists will measure the maximal inspiration pressure (MIP) with the POWER®breathe device of each single patient. Patients will then be instructed to perform inspiratory muscle training at the level of 60% of their individual MIP. Patients are instructed to perform the training containing of 30 breaths twice a day for 14-18 days before surgery. The devices are able to register the performance of each single training session and training results are monitored.
No Intervention: Control arm
No preoperative inspiratory muscle training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: 90 days postoperative
Postoperative complications measured by the comprehensive complication index (CCI) Com-prehensive Complication Index (CCI) 90 days after surgery. The CCI expresses postoperative morbidity on a continuous numeric scale from 0 (no complication) to 100 (death) by weighing all postoperative complications according to the validated Clavien-Dindo classification for their respective severity. It is measured at the end-of hospitalization and 90 days after surgery to include cases in which a readmission was necessary. Postoperative complications are gold standard in evaluation of quality of surgery as they directly reflect the procedures out-come and are most relevant for the patients.
90 days postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative morbidity
Time Frame: At the end of hospitalization and 90 days +/- 2 weeks postoperative
Secondary endpoints are the postoperative morbidity along the classification of Clavien-Dindo at the end of hospitalization as well as 90 days +/- 2 weeks after surgery. This classification consists of five (1-5) severity grades. Grade 1 reflects minor complications, while grade 5 re-flects death. The classification is widely accepted and validated to report postoperative compli-cations.
At the end of hospitalization and 90 days +/- 2 weeks postoperative
Length of hospital stay (LOS)
Time Frame: 90 days postoperative
Length of postoperative hospital stay
90 days postoperative
Readmission rate
Time Frame: 90 days postoperative
Readmission rate as reflection of postoperative outcome.
90 days postoperative
Mortality
Time Frame: 90 days postoperative
Mortality as reflection of postoperative outcome.
90 days postoperative
Maximum inspiratory pressure (MIP)
Time Frame: 5 days after surgery
MIP is the most commonly used measure to evaluate inspiratory muscle strength. Very sensitive in detecting early respiratory muscle dysfunction, it allows for the assessment of ventilatory failure, restrictive lung disease and respirato-ry muscle strength and therefore represents a clinically meaningful trial endpoint.
5 days after surgery
Load
Time Frame: 5 days after surgery
Load (cmH20) (LOAD) is a measure of resistance to inhalation, and represents the pressure generated in the airways due to the force of the inspiratory muscles during a training session. As the training load decays with increasing lung volume (in order to match the length tension characteristics of the inspiratory muscles), the load displayed corresponds to the resistance at the start of inhalation (i.e. at RV). A higher load result means that the patient is training their inspiratory muscles hard-er, leading to stronger muscles. Stronger inspiratory muscles will need to work less hard to cope with the demands of breathing, leading to reduced breathlessness
5 days after surgery
Power (Watt)
Time Frame: 5 days after surgery
POWER is a measure of muscle performance which combines strength and speed of move-ment (Pressure x Flow). More powerful muscles will be more resistant to fatigue at a given level of work and therefore, breathlessness will be reduced. The value displayed is the average power for all breaths in a training session.
5 days after surgery
Sit-to-stand test
Time Frame: 5 days after surgery
During the sit-to-stand test, the quantity [n] how often a patient can sit down on a chair and stand up during 60 seconds is noted. These values are evaluated at admission to hospital for surgery and 5 days after surgery.
5 days after surgery
Energy (Joule)
Time Frame: 5 days after surgery
Breathing Energy) is a measure of the mechanical work (or effort) of breathing during your breathing training session. It is a result which combines the force exerted by your inspiratory muscles and the volume of air inhaled. The higher the value of breathing energy you attain, the longer and harder you have worked your inspiratory muscles.
5 days after surgery
Volume (l)
Time Frame: 5 days after surgery
Lung volume refers to the volume of gas the lungs and it represents the functions of the respiratory muscles and the mechanics of the lung and chest .
5 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Dominique Lisa Birrer, MD, Universitätsspital Zürich (USZ)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2021

Primary Completion (Actual)

October 8, 2025

Study Completion (Actual)

October 8, 2025

Study Registration Dates

First Submitted

September 15, 2020

First Submitted That Met QC Criteria

September 15, 2020

First Posted (Actual)

September 22, 2020

Study Record Updates

Last Update Posted (Estimated)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 4, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on preoperative inspiratory muscle training

Subscribe